A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo
Clinical trial NCT05247489 · COMPLETED
Trial details
- NCT number
- NCT05247489
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-05
- Primary completion
- 2023-12-19
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.